Sign in

CIK 0001497253

  • Non-accelerated filer
  • Smaller reporting company

VivoSim Labs, INC.

Sign in to watch
Ticker
VIVS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
271488943
Phone
+1 858-224-1000
Business address
11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO, CA, 92121
Former names
ORGANOVO HOLDINGS, INC., REAL ESTATE RESTORATION & RENTAL, INC.
Open-market buys, last 90 days
$2,804
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$2,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lialin Tony Serge +$3K Chief Commercial Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2014-08-20 HOWSON TAMAR D Director Grant or award · Stock Option (Right to Buy) +31,500 31,500
2014-08-20 GLOVER JAMES T Director Grant or award · Stock Option (Right to Buy) +31,500 31,500
2014-08-20 Heyman Richard A. Director Grant or award · Stock Option (Right to Buy) +31,500 31,500
2014-08-20 Baltera Robert Jr. Director Grant or award · Stock Option (Right to Buy) +31,500 31,500
2014-06-06 Baltera Robert Jr. Director Option exercise +3,000 $1.00 $3K 144,506
2014-06-06 Baltera Robert Jr. Director Option exercise · Warrant (Right to Buy) −3,000 0
2014-05-08 Renard Michael EVP of Commercial Operations Exercise or conversion +50,000 $1.65 $83K 50,000
2014-05-08 Renard Michael EVP of Commercial Operations Exercise or conversion · Stock Option (Right to Buy) −50,000 500,000
2014-02-21 Renard Michael EVP of Commercial Operations Exercise or conversion +10,000 $1.65 $17K 10,000
2014-02-21 Renard Michael EVP of Commercial Operations Sale −10,000 $10.65 $107K 0
2014-02-21 Renard Michael EVP of Commercial Operations Exercise or conversion · Stock Option (Right to Buy) −10,000 550,000
2014-02-19 MICHAELS BARRY D Chief Financial Officer Grant or award · Stock Option (Right to Buy) +300,000 300,000
2014-02-19 Presnell Sharon Collins EVP, Research & Dev & CTO Grant or award · Stock Option (Right to Buy) +155,000 155,000
2014-02-19 David Eric Chief Strategy Officer Grant or award · Stock Option (Right to Buy) +140,000 140,000
2014-02-19 Renard Michael EVP of Commercial Operations Grant or award · Stock Option (Right to Buy) +155,000 155,000
2014-02-19 Murphy Keith Chairman, CEO and President Grant or award +50,000 6,024,643
2014-02-19 Murphy Keith Chairman, CEO and President Shares withheld for taxes −27,307 $9.86 $269K 5,997,336
2014-02-19 Murphy Keith Chairman, CEO and President Grant or award · Stock Option (Right to Buy) +27,307 27,307
2014-02-19 Murphy Keith Chairman, CEO and President Grant or award · Stock Option (Right to Buy) +550,000 550,000
2014-02-18 Murphy Keith Chairman, CEO and President Sale −100,000 $9.82 $982K 5,974,643

Page 14 of 18 · 356 trades